You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

vascular toxicities

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cell Carcinoma, Bladder Cancer, MSI-H Cancer Trial in Paris (Arterial Doppler for Flow Mediated Reserve measurement)

Recruiting
  • Renal Cell Carcinoma
  • +3 more
  • Arterial Doppler for Flow Mediated Reserve measurement
  • Paris, France
    INstitut Mutualiste Montsouris
Aug 29, 2023

CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors

Recruiting
  • Myocarditis
  • +5 more
  • Paris, France
    AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, C
Aug 19, 2022

Neovascular Age-related Macular Degeneration(nAMD) Trial in Shanghai, Tianjin (HG202)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration(nAMD)
  • HG202
  • Shanghai, Shanghai, China
  • +1 more
Sep 4, 2023

GSD1 Trial in Worldwide (DTX401)

Completed
Has Results
  • GSD1
  • DTX401
  • steroid regimen
  • Farmington, Connecticut
  • +5 more
Oct 25, 2022

Esophageal Cancer Trial in Indianapolis, Iowa City, Ann Arbor (Durvalumab)

Completed
Has Results
  • Esophageal Cancer
  • Indianapolis, Indiana
  • +2 more
May 5, 2022

Evaluation of High Dose Methotrexate Toxicity

Not yet recruiting
  • Methotrexate Toxicity
  • blood methotrexate level and Cystatin C level
  • (no location specified)
Nov 7, 2023

Hepatocellular Carcinoma, Hepatoma Trial in Baltimore (sorafenib, LC Bead-TACE)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Hepatoma
  • Baltimore, Maryland
    The Johns Hopkins Hospital
Oct 15, 2021

Chronic Myelomonocytic Leukemia Trial in Indianapolis (CD4CAR)

Not yet recruiting
  • Chronic Myelomonocytic Leukemia
  • CD4CAR
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
Oct 2, 2023

Renal Cell Carcinoma Trial in Chapel Hill (Survey Questionnaire)

Recruiting
  • Renal Cell Carcinoma
  • Survey Questionnaire
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Oct 19, 2022

Osteosarcoma Trial in United States (Avelumab, Questionnaires)

Active, not recruiting
Has Results
  • Osteosarcoma
  • Los Angeles, California
  • +3 more
Aug 22, 2022

NSCLC Trial in San Antonio (bexmarilimab (FP-1305), Pembrolizumab)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • San Antonio, Texas
    Mays Cancer Center, UT Health San Antonio
May 13, 2022

Pancreatic Cancer, Pancreas Adenocarcinoma, Advanced Pancreatic Cancer Trial in United States (Pembrolizumab, paricalcitol, )

Completed
Has Results
  • Pancreatic Cancer
  • +4 more
  • Scottsdale, Arizona
  • +5 more
Dec 1, 2022

Relapsed/Refractory Multiple Myeloma Trial in United States (KITE-585, Cyclophosphamide, Fludarabine)

Terminated
Has Results
  • Relapsed/Refractory Multiple Myeloma
  • KITE-585
  • +2 more
  • Los Angeles, California
  • +8 more
Oct 4, 2022

To Determine the Optimal Doses of Adrenaline in Preventing Blood Loos in Participants Undergoing Supraclavicular Flap Surgery

Not yet recruiting
  • To Determine the Optimal Doses of Adrenaline in Preventing Blood Loos in Participants Undergoing Supraclavicular Flap Surgery
  • Epinephrine injection
  • (no location specified)
Dec 31, 2022

Carcinoma, Squamous Cell of Head and Neck Trial in San Antonio (Docetaxel, Cisplatin, Cetuximab and Bevacizumab (TPE-A) Followed

Active, not recruiting
  • Carcinoma, Squamous Cell of Head and Neck
  • Docetaxel, Cisplatin, Cetuximab and Bevacizumab (TPE-A) Followed by Concurrent Radiation, Cisplatin, Cetuximab and Bevacizumab (XPE-A), surgery
  • San Antonio, Texas
    Cancer Therapy and Research Center at UTHSCSA
Dec 15, 2021

Acute Myeloid Leukemia Trial in Baltimore, New York, Chapel Hill (Alvocidib, Cytarabine, Daunorubicin)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
  • +2 more
Apr 4, 2022

Toxicities in Gastrointestinal and Sarcomatous Malignancies

Not yet recruiting
  • Sarcoma
  • Gastrointestinal Cancer
  • Survey
  • Toxicity Assessments
  • (no location specified)
Feb 23, 2023

Serial PET MPI in Patients Undergoing Cancer Treatment

Enrolling by invitation
  • Cancer
  • +3 more
    • Los Angeles, California
      West Los Angeles VA Medical Center
    Jun 12, 2023

    Solid Tumor Trial in Shanghai (HB002.1T)

    Completed
    • Solid Tumor
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    Jul 26, 2021

    Carcinoma, Renal Cell Trial in France (Tivozanib, Nivolumab)

    Completed
    • Carcinoma, Renal Cell
    • Bordeaux, France
    • +3 more
    Dec 2, 2021

    Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

    Recruiting
    • Anatomic Stage I Breast Cancer AJCC v8
    • +20 more
    • Best Practice
    • +2 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Jan 5, 2023

    Lupus Nephritis, Chronic Kidney Diseases Trial in Hong Kong (Dapagliflozin 10mg Tab, Standard maintenance therapy)

    Not yet recruiting
    • Lupus Nephritis
    • Chronic Kidney Diseases
    • Dapagliflozin 10mg Tab
    • Standard maintenance therapy
    • Hong Kong, Hong Kong
      Queen Mary Hospital
    Nov 24, 2023

    Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis Trial in Buffalo (drug, dietary supplement, other)

    Terminated
    • Essential Thrombocythemia
    • +2 more
    • Arsenic Trioxide
    • +3 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 20, 2022

    Improving Care Pathway Using Simplified Digital Tools for

    Not yet recruiting
    • Oncology
    • +5 more
    • Nouveal numeric application "Onco'nect"
    • (no location specified)
    Jul 21, 2023

    Locally Advanced Breast Carcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma Trial in United States (Laboratory

    Active, not recruiting
    Has Results
    • Locally Advanced Breast Carcinoma
    • +7 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Duarte, California
    • +3 more
    Jan 31, 2023